News

The Class 1 resubmission follows a complete response letter issued by the FDA that referenced previously observed deficiencies at a Boehringer Ingelheim facility where empagliflozin will be manufactured.

Sucampo CEO Peter Greenleaf said that with more than eight million prescriptions dispensed globally over the past eight years, Amitiza has demonstrated to be an effective treatment option

Designed to deliver brief, controlled pulses of nitric oxide, a selective, short-acting pulmonary vasodilator that are inhaled by the patient, the portable device INOpulse enables the treatment of

Manufactured in accordance with the current GMP standards, the therapeutic vaccine is based on a blend of inactivated lactobacilli strains. The primary endpoint of the double-blind and placebo-controlled

The bivalent rLP2086 vaccine is indicated for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 to 25-year-olds. Pfizer vaccine research and development

According to IMS, for the year ended April 2014 total sales of Codeine Sulfate Tablets USP 15mg, 30mg and 60mg at Average Wholesale Price (AWP) were about $4.3m.

The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from three area locations and position Pfizer in closer proximity to leading academic institutions, hospitals and patient

The purchase order is for AllStar Health Brands’, TapouT Muscle Recovery Pain Relief, Muscle Growth Supplement and TapouT Muscle Post Recovery Supplement. The purchase order marks AllStar’s continued

Novartis’ facility in Holly Springs is the first US facility of its kind and is now approved for commercial production. The facility will produce seasonal and pre-pandemic influenza